🇺🇸 FDA
Pipeline program

Fostamatinib Disodium tablet 100 mg

C-935788-051

Phase 2 small_molecule terminated

Quick answer

Fostamatinib Disodium tablet 100 mg for IGA Nephropathy is a Phase 2 program (small_molecule) at RIGEL PHARMACEUTICALS INC with 1 ClinicalTrials.gov record(s).

Program details

Company
RIGEL PHARMACEUTICALS INC
Indication
IGA Nephropathy
Phase
Phase 2
Modality
small_molecule
Status
terminated

Clinical trials